Cargando…

New Insights into the Role of Sphingolipid Metabolism in Melanoma

Cutaneous melanoma is a deadly skin cancer whose aggressiveness is directly linked to its metastatic potency. Despite remarkable breakthroughs in term of treatments with the emergence of targeted therapy and immunotherapy, the prognosis for metastatic patients remains uncertain mainly because of res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrié, Lorry, Virazels, Mathieu, Dufau, Carine, Montfort, Anne, Levade, Thierry, Ségui, Bruno, Andrieu-Abadie, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565650/ https://www.ncbi.nlm.nih.gov/pubmed/32858889 http://dx.doi.org/10.3390/cells9091967

Ejemplares similares

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma
por: Bilal, Fatima, et al.
Publicado: (2019)

Anti-TNF, a magic bullet in cancer immunotherapy?
por: Montfort, Anne, et al.
Publicado: (2019)

Sphingolipids modulate the epithelial–mesenchymal transition in cancer
por: Levade, T, et al.
Publicado: (2015)

The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Bertrand, Florie, et al.
Publicado: (2017)

The Tricyclodecan-9-yl-xanthogenate D609 Triggers Ceramide Increase and Enhances FasL-Induced Caspase-Dependent and -Independent Cell Death in T Lymphocytes
por: Milhas, Delphine, et al.
Publicado: (2012)

Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
por: Dubot, Patricia, et al.
Publicado: (2020)

Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer
por: Dubot, Patricia, et al.
Publicado: (2022)

Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk
por: Lafont, Elodie, et al.
Publicado: (2010)

Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma
por: Mrad, Marguerite, et al.
Publicado: (2016)

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
por: Imbert, Caroline, et al.
Publicado: (2020)

Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells
por: Bandet, Cécile L., et al.
Publicado: (2019)

Autophagy in the light of sphingolipid metabolism
por: Harvald, Eva Bang, et al.
Publicado: (2015)

Topical Collection: New Insights on Sphingolipids in Health and Disease
por: Huwiler, Andrea
Publicado: (2023)

An Introduction to Sphingolipid Metabolism and Analysis by New Technologies
por: Chen, Yanfeng, et al.
Publicado: (2010)

On-Tissue Localization of Ceramides and Other Sphingolipids by MALDI Mass Spectrometry Imaging
por: Jones, E. Ellen, et al.
Publicado: (2014)

IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
por: Mas, Emmanuel, et al.
Publicado: (2009)

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
por: Quinville, Brianna M., et al.
Publicado: (2021)

Computational modeling of sphingolipid metabolism
por: Wronowska, Weronika, et al.
Publicado: (2015)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Editorial: Sphingolipid metabolism and cancer
por: Ivanova, Margarita M., et al.
Publicado: (2022)

Sphingolipid Metabolism and Obesity-Induced Inflammation
por: Kang, Se-Chan, et al.
Publicado: (2013)

Sphingolipids in cardiovascular diseases and metabolic disorders
por: Borodzicz, Sonia, et al.
Publicado: (2015)

Sphingolipid Metabolism Perturbations in Rett Syndrome
por: Cappuccio, Gerarda, et al.
Publicado: (2019)

Colon Cancer and Perturbations of the Sphingolipid Metabolism
por: Machala, Miroslav, et al.
Publicado: (2019)

The Role of Sphingolipid Metabolism in Bone Remodeling
por: Qi, Tang, et al.
Publicado: (2021)

Evaluation of sphingolipid metabolism on diabetic retinopathy
por: Ensari Delioğlu, Ezgi Naz, et al.
Publicado: (2021)

Sphingolipid metabolism and signaling in cardiovascular diseases
por: Borodzicz-Jażdżyk, Sonia, et al.
Publicado: (2022)

Gene Therapy of Sphingolipid Metabolic Disorders
por: Shaimardanova, Alisa A., et al.
Publicado: (2023)

Editorial: Sphingolipid metabolism dysfunction in cancer
por: El Ridi, Rashika, et al.
Publicado: (2023)

Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
por: Di Pardo, Alba, et al.
Publicado: (2018)

The Equilibria of Sphingolipid-Cholesterol and Sphingolipid–Sphingolipid in Monolayers at the Air–Water Interface
por: Petelska, Aneta Dorota, et al.
Publicado: (2012)

Novel Insight into the Serum Sphingolipid Fingerprint Characterizing Longevity
por: Barbacini, Pietro, et al.
Publicado: (2022)

Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis
por: MINA, JOHN G. M., et al.
Publicado: (2018)

Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma
por: Chi, Hao, et al.
Publicado: (2022)

Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
por: Merrill, Alfred H.
Publicado: (2011)

Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
por: Don, Anthony S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8g1h7ovavtj0q240fr0rpv801o